ALPINE IMMUNE SCIENCES, INC. Conversion of Stock, Amount Converted
ALPINE IMMUNE SCIENCES, INC. reported Conversion of Stock, Amount Converted of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2020-03-30
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for the quarter ending 2018-12-31 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for the quarter ending 2017-12-31 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for the quarter ending 2015-12-31 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for the quarter ending 2015-09-30 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for fiscal 2019 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for fiscal 2017 was $49.20M.
- ALPINE IMMUNE SCIENCES, INC. conversion of stock, amount converted for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-30 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $49.20M 10-K · filed 2020-03-30 | ||
| 2017-09-30 | $49.20M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-13 | $41.88M 10-K · filed 2017-02-13 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $41.88M 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $41.88M 10-Q · filed 2016-08-02 |